We have had our second meeting with the ePRMS system, and committee members are very pleased with the ease in which reviews can be completed. The meetings run smoothly and are on time.
Madison, WI (PRWEB) September 29, 2006
Three premier cancer centers have bid farewell to heavy binders, hours standing at the photocopier, paper memos, and treks across campus. This fall, they are revolutionizing the management of their Protocol Review and Monitoring Committees with something new. It’s called ePRMS and it is the result of a concerted effort to address a fundamental challenge facing today’s cancer research facilities.
- ePRMS is a beginning-to-end system for submitting, tracking, reviewing, revising, and approving scientific reviews for the lifetime of a protocol.
- Three NCI designated cancer centers collaborated with PercipEnz Technologies to develop the new module: The Karmanos Cancer Institute, The Cancer Institute of New Jersey, and the Indiana University Cancer Center.
- About one year after the September 2005 project kick-off, ePRMS is being actively used by all three collaborators.
- The new module is seamlessly integrated and comes standard with PercipEnz’s flagship product, Oncore™.
- With improvements to every step in the process, ePRMS reduces the time it takes to open a new protocol―a key barrier to accrual.
- Users can be geographically dispersed. The on-line submission feature offers immediate availability of protocol documents to committee members as they access their assignments over a secure Internet connection.
- ePRMS “understands” the workflow of protocol review & monitoring committees (also called scientific review committees). It streamlines review procedures for the lifetime of a protocol largely through improved control and automation of committee coordination tasks.
To request access to a video presentation, click here
To download an eBook on this topic, visit: http://www.onsemble.net
- "We have had our second meeting with the ePRMS system, and committee members are very pleased with the ease in which reviews can be completed. The meetings run smoothly and are on time." ― Beth Golden, RN, BSN, Director, Clinical Trials Office, Karmanos Cancer Institute.
- “We just had our first SRC meeting using ePRMS and the response was overwhelmingly positive. We are now one hour past the meeting and we have every reviewers’ notes except one—this typically takes a week or longer!” ― Erin Pennington, Protocol Development Coordinator at Indiana University Cancer Center
- “You can tell how well the collaboration went by the fact that the system is now working at three centers. ―Dr. Henry Durivage, Director of Human Research Services at The Cancer Institute of New Jersey.
About the Oncore People:
PercipEnz Technologies, Inc. develops and markets specialized informatics solutions for managing the clinical and translational research enterprise.
By adopting a highly collaborative product development process, PercipEnz gathers, distills and fine-tunes the best ideas from world-class research institutions to deliver solutions addressing key operational challenges.